Variant report
Variant | nsv874886 |
---|---|
Chromosome Location | chr2:113786504-113792776 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:113778463..113783936-chr2:113784891..113788081,5 | K562 | blood: | |
2 | chr2:113787918..113790326-chr2:113790543..113792272,2 | K562 | blood: | |
3 | chr2:113778463..113780634-chr2:113785926..113787939,2 | K562 | blood: | |
4 | chr2:113780916..113783936-chr2:113784891..113788063,3 | K562 | blood: | |
5 | chr2:113787918..113790326-chr2:113790543..113792272,2 | K562 | blood: | |
6 | chr2:113716174..113716685-chr2:113789552..113790103,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34856653 | chr2:113786504-113786505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187035339 | chr2:113786507-113786508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145021212 | chr2:113786540-113786541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147435589 | chr2:113786553-113786554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191826739 | chr2:113786568-113786569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182588966 | chr2:113786587-113786588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200349123 | chr2:113786592-113786593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs267598838 | chr2:113786608-113786609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185272483 | chr2:113786624-113786625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558575436 | chr2:113786632-113786633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141108409 | chr2:113786637-113786638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368357447 | chr2:113786660-113786661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572261251 | chr2:113786679-113786680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189984235 | chr2:113786707-113786708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35872763 | chr2:113786717-113786718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373031656 | chr2:113786764-113786765 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570954982 | chr2:113786778-113786779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543526359 | chr2:113786784-113786785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539977008 | chr2:113786791-113786792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182595117 | chr2:113786818-113786819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3948121 | chr2:113786833-113786834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
22 | rs34101340 | chr2:113786913-113786914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552162368 | chr2:113787027-113787028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370806395 | chr2:113787039-113787040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559836644 | chr2:113787044-113787045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187056625 | chr2:113787070-113787071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114007384 | chr2:113787071-113787072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568625025 | chr2:113787122-113787123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537216703 | chr2:113787150-113787151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111671518 | chr2:113787154-113787155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550680889 | chr2:113787193-113787194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575397550 | chr2:113787200-113787201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570561644 | chr2:113787239-113787240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191471844 | chr2:113787269-113787270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4849143 | chr2:113787356-113787357 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs183252601 | chr2:113787365-113787366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377507334 | chr2:113787450-113787451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75829794 | chr2:113787482-113787483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34098499 | chr2:113787485-113787486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554500568 | chr2:113787529-113787530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574708266 | chr2:113787538-113787539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543597126 | chr2:113787548-113787549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563382342 | chr2:113787572-113787573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554834664 | chr2:113787585-113787586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545864375 | chr2:113787591-113787592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139736130 | chr2:113787606-113787607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35391805 | chr2:113787622-113787623 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs34352179 | chr2:113787636-113787637 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs370726062 | chr2:113787644-113787645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34345657 | chr2:113787674-113787675 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113765600-113797400 | Weak transcription | Gastric | stomach |
2 | chr2:113785800-113787400 | Enhancers | K562 | blood |
3 | chr2:113786000-113786600 | Enhancers | Placenta Amnion | Placenta Amnion |
4 | chr2:113787400-113788400 | Weak transcription | K562 | blood |
5 | chr2:113788400-113789000 | Enhancers | K562 | blood |
6 | chr2:113789000-113789400 | Weak transcription | K562 | blood |
7 | chr2:113789400-113792600 | Enhancers | K562 | blood |
8 | chr2:113789600-113789800 | Enhancers | Esophagus | oesophagus |
9 | chr2:113789800-113790000 | Flanking Active TSS | Esophagus | oesophagus |
10 | chr2:113790000-113790400 | Active TSS | Esophagus | oesophagus |
11 | chr2:113790200-113790400 | Enhancers | Stomach Mucosa | stomach |
12 | chr2:113790600-113794200 | Weak transcription | Stomach Mucosa | stomach |